When sleep breaks, cycles shift and anxiety arrives uninvited somewhere in your 40s, wanting a definitive test is the most natural response in the world. A single blood draw, a number, an answer. The uncomfortable truth about perimenopause is that the test most people imagine does not work the way they hope, and UK guidance explicitly says so. That is not a gap in medicine so much as a fact about the biology: you cannot take a still photograph of a storm and call it the weather. This article explains what tests exist, when they genuinely help, and what actually settles the question for most women.
Why the obvious test fails
The obvious test is FSH, follicle-stimulating hormone. As ovarian response declines, the pituitary shouts louder, and FSH rises; in established menopause it sits high and stays there. The problem is the phase before: during perimenopause the ovaries respond erratically rather than not at all, so FSH spikes in some weeks and returns to entirely premenopausal levels in others. A woman deep in symptomatic perimenopause can test normal on Tuesday and elevated three weeks later. Oestrogen wobbles the same way, and both are further scrambled by hormonal contraception, which many women in their 40s use. The result: a single normal result cannot exclude perimenopause, and a single raised result adds little to what a good history already shows. This is precisely why NICE guidance tells clinicians not to use FSH to diagnose perimenopause or menopause in women over 45 on symptoms alone.
How diagnosis actually works over 45
Over 45, the diagnosis is clinical: the pattern of vasomotor symptoms, hot flushes and night sweats, alongside cycle changes and the wider constellation, sleep disruption, mood shifts, brain fog, joint aches, is the diagnostic instrument, and it outperforms any single blood value. This can feel anticlimactic to a patient braced for laboratory proof, but it has a liberating consequence: treatment does not wait for a number. If the pattern fits and symptoms affect your life, the conversation about options, HRT, non-hormonal treatments, CBT, lifestyle change, can start today. The corollary is that your evidence gathering matters: two to three months of tracking symptoms against your cycle, on paper or any period app, converts I feel awful lately into a pattern a GP can read in a minute, and it is genuinely the most useful test available to you.
When blood tests genuinely earn their place
Under 45, the calculation changes, because perimenopause becomes less likely and lookalike conditions deserve more suspicion. Guidance supports considering FSH testing in women aged 40 to 45 with menopausal symptoms and cycle change, and it becomes important under 40, where two elevated FSH results taken four to six weeks apart support a diagnosis of premature ovarian insufficiency, a condition that needs proper specialist attention and long-term hormone protection for bones and heart. The other legitimate role for blood tests at any age is excluding the imposters: thyroid disease reproduces flushes, mood change, cycle disruption and fatigue almost perfectly; iron deficiency mimics the exhaustion and cognitive fog; and both are common, cheap to test and fully treatable. A GP working through new symptoms in a woman in her 40s will often check thyroid and ferritin not to diagnose perimenopause but to make sure it is not something else wearing its coat.
Home kits and online tests, honestly appraised
Pharmacy and online menopause tests are almost all FSH tests, urine or fingerprick, and they inherit FSH's core limitation with none of the clinical context: one snapshot of a hormone that swings weekly. A positive result in a symptomatic 48-year-old tells her what her symptoms already said; a negative result in the same woman risks falsely reassuring her away from help she would benefit from, which is the actively harmful outcome. Multi-hormone panels sold online suffer the same physics with more decimal places. If you enjoy data, nothing forbids testing, but spend the money knowing what it can and cannot answer, and never let a normal kit result overrule a persuasive symptom pattern. The one test category with a different purpose, anti-Müllerian hormone, estimates ovarian reserve for fertility planning; it is not a menopause timing crystal ball and guidance does not endorse it as one.
Making the appointment count
Whether or not any test happens, the GP conversation is where diagnosis actually occurs, and it rewards preparation. Bring the diary. Name the suspicion explicitly, I think this may be perimenopause, rather than presenting symptoms one by one, which invites one-by-one answers. Say clearly how life is affected: sleep, work, relationships, mood. Ask directly what the options are, and if HRT interests you, say so; over 45 with a typical pattern, nothing about starting it requires a blood test first. If the response is a test-and-wait when your pattern is clear, it is entirely reasonable to cite the NICE position and ask what the test would change. And if the conversation stalls, ask whether the practice has a clinician with a menopause interest, or consider a specialist menopause service. Persistence here is not fussiness; it is how under-recognised conditions get recognised.
The answer to is there a test, then: over 45, you are the test, your pattern, tracked honestly, read by a competent clinician; under 45, blood tests join the investigation, and under 40 they become central; and at every age the most valuable laboratory work may be excluding thyroid and iron problems masquerading as hormones. Skip the kits or enjoy them sceptically, but do not let any single number, normal or otherwise, overrule months of your own evidence. For what the symptom pattern looks like in full, see our complete guide to perimenopause symptoms, and for the treatment landscape, our HRT guides.
